222 related articles for article (PubMed ID: 6345330)
1. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.
Wahren J; Denis J; Desurmont P; Eriksson LS; Escoffier JM; Gauthier AP; Hagenfeldt L; Michel H; Opolon P; Paris JC; Veyrac M
Hepatology; 1983; 3(4):475-80. PubMed ID: 6345330
[TBL] [Abstract][Full Text] [Related]
2. Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy.
Freund H; Dienstag J; Lehrich J; Yoshimura N; Bradford RR; Rosen H; Atamian S; Slemmer E; Holroyde J; Fischer JE
Ann Surg; 1982 Aug; 196(2):209-20. PubMed ID: 6284073
[TBL] [Abstract][Full Text] [Related]
3. Branched chain amino acid therapy in liver disease.
Maddrey WC
J Am Coll Nutr; 1985; 4(6):639-50. PubMed ID: 3935706
[TBL] [Abstract][Full Text] [Related]
4. Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study.
Malaguarnera M; Risino C; Cammalleri L; Malaguarnera L; Astuto M; Vecchio I; Rampello L
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):762-70. PubMed ID: 19357525
[TBL] [Abstract][Full Text] [Related]
5. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy.
Eriksson LS; Persson A; Wahren J
Gut; 1982 Oct; 23(10):801-6. PubMed ID: 6749604
[TBL] [Abstract][Full Text] [Related]
6. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy.
Morioka S; Kanai K; Kako M; Nakajima T; Yoshimi T; Masaka M; Sudo K; Kanno T
Gastroenterol Jpn; 1983 Dec; 18(6):553-9. PubMed ID: 6368305
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis.
Kawaguchi T; Taniguchi E; Sata M
Nutr Clin Pract; 2013 Oct; 28(5):580-8. PubMed ID: 23945292
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.
Horst D; Grace ND; Conn HO; Schiff E; Schenker S; Viteri A; Law D; Atterbury CE
Hepatology; 1984; 4(2):279-87. PubMed ID: 6706302
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia in hepatic encephalopathy: the effect of infusion of an amino acid mixture with excess branched chain amino acids.
Bauer AG; Wilson JH; Lamberts SW; Blom W
Hepatogastroenterology; 1983 Oct; 30(5):174-7. PubMed ID: 6416978
[TBL] [Abstract][Full Text] [Related]
10. Branched-chain amino acids for people with hepatic encephalopathy.
Gluud LL; Dam G; Les I; Córdoba J; Marchesini G; Borre M; Aagaard NK; Vilstrup H
Cochrane Database Syst Rev; 2015 Feb; (2):CD001939. PubMed ID: 25715177
[TBL] [Abstract][Full Text] [Related]
11. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial.
Kanematsu T; Koyanagi N; Matsumata T; Kitano S; Takenaka K; Sugimachi K
Surgery; 1988 Sep; 104(3):482-8. PubMed ID: 2842882
[TBL] [Abstract][Full Text] [Related]
12. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Marchesini G; Dioguardi FS; Bianchi GP; Zoli M; Bellati G; Roffi L; Martines D; Abbiati R
J Hepatol; 1990 Jul; 11(1):92-101. PubMed ID: 2204661
[TBL] [Abstract][Full Text] [Related]
13. Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials.
Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Risum N; Vilstrup H
J Nutr; 2013 Aug; 143(8):1263-8. PubMed ID: 23739310
[TBL] [Abstract][Full Text] [Related]
14. Branched-chain amino acids for hepatic encephalopathy.
Als-Nielsen B; Koretz RL; Kjaergard LL; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD001939. PubMed ID: 12804416
[TBL] [Abstract][Full Text] [Related]
15. Supplementation with Synbiotics and/or Branched Chain Amino Acids in Hepatic Encephalopathy: A Pilot Randomised Placebo-Controlled Clinical Study.
Vidot H; Cvejic E; Finegan LJ; Shores EA; Bowen DG; Strasser SI; McCaughan GW; Carey S; Allman-Farinelli M; Shackel NA
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31390762
[TBL] [Abstract][Full Text] [Related]
16. Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease.
O'Keefe SJ; Ogden J; Dicker J
JPEN J Parenter Enteral Nutr; 1987; 11(5):447-53. PubMed ID: 3116290
[TBL] [Abstract][Full Text] [Related]
17. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
Bianchi GP; Marchesini G; Zoli M; Abbiati R; Ferrario E; Fabbri A; Pisi E
Hepatogastroenterology; 1992 Oct; 39(5):443-6. PubMed ID: 1459529
[TBL] [Abstract][Full Text] [Related]
18. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis.
Vilstrup H; Gluud C; Hardt F; Kristensen M; Køhler O; Melgaard B; Dejgaard A; Hansen BA; Krintel JJ; Schütten HJ
J Hepatol; 1990 May; 10(3):291-6. PubMed ID: 2195106
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hepatic encephalopathy with branched-chain amino acids (BCAA) by oral route: II. Chronic hepatic encephalopathy].
Caballería Rovira E; Arago López JV; Masso Ubeda RM; Vidal Clemente JL; Sanchís Closa A
Rev Esp Enferm Apar Dig; 1987 Sep; 72(3):201-5. PubMed ID: 3685578
[No Abstract] [Full Text] [Related]
20. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
